Follow The Filings

GSK GSK

Health Care, filed as GSK PLC (SPONSORED ADR), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 3

  • 8 Owners
  • #150
  • Max 3.5%
  • Master 0.15%
  • $2.6B
  • 1 add 3 reduce 3 small

In 2026 Q2 Richard Pzena added to GSK, while Hillman Capital Management, Dodge & Cox, and Sarah Ketterer trimmed.

Who owns this now

Largest portfolio weights among holders, up to 3.5% (Hillman Capital Management). Not free-float ownership.

  1. Hillman Capital Management Reduce 3.5%
  2. Michael Krensavage 1.9%
  3. Dodge & Cox Reduce 1.3%
  4. Kahn Brothers Group Reduce 1.3%
  5. Tweedy, Browne Co. Reduce 0.32%
  6. Murray Stahl Reduce 0.01%

Who owns GSK

Sorted by value, long equity only, as of 2026 Q2.

History
Dodge & Cox 1.3%, was 1.8% Reduce −17.8% 48,197,514 $2.5B History
Kahn Brothers Group 1.3%, was 1.6% Small trim −1.6% 158,438 $8.3M History
Michael Krensavage, Krensavage Asset Management 1.9% Hold 96,729 $5.1M History
Hillman Capital Management 3.5%, was 3.7% Reduce −5.2% 92,383 $4.8M History
Tweedy, Browne Co. 0.32%, was 0.35% Small trim −0.3% 81,527 $4.3M History
Richard Pzena, Pzena Investment Management <0.01% Add +30.2% 24,507 $1.3M History
Murray Stahl, Horizon Kinetics Asset Management 0.01% Small trim −1.5% 24,046 $1.3M History
Sarah Ketterer, Causeway Capital Management <0.01% Reduce −35.5% 7,163 $375K History

8 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Congress

6 members of Congress traded GSK in the last three years: 8 buys and 6 sales. 4 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $15K–$50K Mar 30 filed Jul 21
  2. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Oct 31, 2025 filed Nov 21, 2025
  3. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Oct 30, 2025 filed Nov 21, 2025
  4. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Oct 30, 2025 filed Nov 21, 2025
  5. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Sep 23, 2025 filed Oct 10, 2025
  6. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Aug 4, 2025 filed Sep 12, 2025

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K US FDA APPROVES HIBSAGO FOR CHRONIC HEPATITIS B Filing Doc
6-K JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER Filing Doc
6-K RIS-REZ POSITIVE EARLY DATA IN LUNG CANCER Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
6-K WENDY BECKER CBE - NEW DIRECTORSHIP Filing Doc
6-K ADMISSION TO TRADING Filing Doc
6-K TOTAL VOTING RIGHTS Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
6-K Filing Doc
6-K GSK TO ACQUIRE T CELL-ENGAGER FOR MULTIPLE MYELOMA Filing Doc
6-K RIS-REZ POSITIVE PH 3 OS LUNG CANCER DATA IN CHINA Filing Doc
6-K JIDEYTRO POSITIVE DATA FOR ROS1-POSITIVE NSCLC Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
424B2 Filing Doc
6-K JAPAN APPROVAL OF SHINGRIX IN A PREFILLED SYRINGE Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
6-K DIRECTOR/PDMR SHAREHOLDING Filing Doc
424B2 Filing Doc
6-K Filing Doc
6-K TOTAL VOTING RIGHTS Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures, as tagged in Form 10-K

Newly public, no 10-K financials yet. See the 424B2.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.